ME01514B - Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma - Google Patents
Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasomaInfo
- Publication number
- ME01514B ME01514B MEP-2013-15A MEP1513A ME01514B ME 01514 B ME01514 B ME 01514B ME P1513 A MEP1513 A ME P1513A ME 01514 B ME01514 B ME 01514B
- Authority
- ME
- Montenegro
- Prior art keywords
- class
- inhibitors
- histone
- combination
- combined activity
- Prior art date
Links
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP06120726 | 2006-09-15 | ||
| US91589507P | 2007-05-03 | 2007-05-03 | |
| PCT/EP2007/059518 WO2008031817A2 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
| EP07803397A EP2066327B1 (en) | 2006-09-15 | 2007-09-11 | Histone deacetylase inhibitors with combined activity on class-i and class-iib histone deacetylases in combination with proteasome inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ME01514B true ME01514B (me) | 2014-04-20 |
Family
ID=41040414
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MEP-2013-15A ME01514B (me) | 2006-09-15 | 2007-09-11 | Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma |
Country Status (12)
| Country | Link |
|---|---|
| CN (1) | CN101516374B (xx) |
| BR (1) | BRPI0716992A2 (xx) |
| DK (1) | DK2066327T3 (xx) |
| ES (1) | ES2399670T3 (xx) |
| ME (1) | ME01514B (xx) |
| NZ (1) | NZ575030A (xx) |
| PT (1) | PT2066327E (xx) |
| RS (1) | RS52638B (xx) |
| SG (1) | SG177219A1 (xx) |
| SI (1) | SI2066327T1 (xx) |
| UA (1) | UA97249C2 (xx) |
| ZA (1) | ZA200901818B (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8957066B2 (en) * | 2011-02-28 | 2015-02-17 | Biomarin Pharmaceutical Inc. | Histone deacetylase inhibitors |
| CN107095871A (zh) * | 2016-02-22 | 2017-08-29 | 中国科学院上海巴斯德研究所 | Quisinostat，一种新型的高效抗疟药物 |
| JP2019527226A (ja) * | 2016-07-20 | 2019-09-26 | ザ トラスティース オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | ヒストンアセチルトランスフェラーゼ活性化剤及び組成物並びにそれらの使用 |
| CN114409638B (zh) * | 2022-02-09 | 2023-02-14 | 深圳大学 | 组蛋白去乙酰化酶8选择性降解剂、制备方法及其在抗肿瘤活性中的应用 |
| CN115028678A (zh) * | 2022-07-08 | 2022-09-09 | 杭州医学院 | 基于vhl配体诱导bcr-abl蛋白降解的双功能分子及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4948403B2 (ja) * | 2004-07-28 | 2012-06-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | ヒストン・デアセチラーゼの新インヒビターとしての置換インドリルアルキルアミノ誘導体 |
-
2007
- 2007-09-11 CN CN200780034143.2A patent/CN101516374B/zh active Active
- 2007-09-11 RS RS20130038A patent/RS52638B/en unknown
- 2007-09-11 SI SI200731143T patent/SI2066327T1/sl unknown
- 2007-09-11 ES ES07803397T patent/ES2399670T3/es active Active
- 2007-09-11 DK DK07803397.4T patent/DK2066327T3/da active
- 2007-09-11 NZ NZ575030A patent/NZ575030A/en unknown
- 2007-09-11 BR BRPI0716992-2A2A patent/BRPI0716992A2/pt not_active Application Discontinuation
- 2007-09-11 PT PT78033974T patent/PT2066327E/pt unknown
- 2007-09-11 SG SG2011092863A patent/SG177219A1/en unknown
- 2007-09-11 UA UAA200900388A patent/UA97249C2/ru unknown
- 2007-09-11 ME MEP-2013-15A patent/ME01514B/me unknown
-
2009
- 2009-03-13 ZA ZA200901818A patent/ZA200901818B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2066327T1 (sl) | 2013-04-30 |
| CN101516374A (zh) | 2009-08-26 |
| DK2066327T3 (da) | 2013-02-11 |
| BRPI0716992A2 (pt) | 2013-09-17 |
| CN101516374B (zh) | 2013-04-24 |
| ES2399670T3 (es) | 2013-04-02 |
| RS52638B (en) | 2013-06-28 |
| PT2066327E (pt) | 2013-02-06 |
| NZ575030A (en) | 2012-07-27 |
| ZA200901818B (en) | 2010-05-26 |
| UA97249C2 (ru) | 2012-01-25 |
| SG177219A1 (en) | 2012-01-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016002589A1 (es) | Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348). | |
| ECSP056253A (es) | Composicion farmaceutica que contiene un inhibidor de histona desacetilasa | |
| EA201200550A1 (ru) | Фармацевтические композиции, включающие bi-1356 и метформин | |
| ATE516041T1 (de) | Synergistische zusammensetzungen mit fk-228 | |
| TW200800987A (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
| CL2007001391A1 (es) | Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico | |
| TW200728285A (en) | Diacylindazole derivatives as inhibitors of lipases and phospholipases | |
| EA200970081A1 (ru) | Соединения, обладающие потенциирующим действием в отношении активности этионамида, и их применения | |
| TW200722421A (en) | Azole derivatives as inhibitors of lipases and phospholipases | |
| MX2014011827A (es) | Inhibidores de 1,3,4 - oxadiazol y 1,3,4 - tiadiazol b-lactamasa. | |
| CR10663A (es) | 4-[4-({[4-cloro-3-(trifluorometil)fenil]carbamoil}amino)-3-fluorofenoxi]-n-metilpiridina-2-carboxamida monohidrato | |
| CL2007002167A1 (es) | Compuestos derivados de indol, antagonistas iap; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de cancer. | |
| ECSP088904A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
| NO20084253L (no) | Tetrahydroisokinolinderivater for a forbedre hukommelsesfunksjon | |
| GT200600097A (es) | Formas farmaceuticas con propiedades farmacocineticas mejoradas | |
| TW200730513A (en) | Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases | |
| CY1126067T1 (el) | Συντηγμενες πυρρολινες που δρουν σαν ειδικοι για ουβικιτινη αναστολεις πρωτεασης 30 (usp30) | |
| ME01514B (me) | Inhibitori histonske deacetilaze sa spojenom aktivnosti protiv histonskih deacetilaza klase-l i klase-IIB u kombinaciji sa inhibitorima proteasoma | |
| CY1112122T1 (el) | Συνθεση σφαιριδιου λιποϊκου οξεος | |
| CY1108231T1 (el) | Σταθερη στερεα δοσολογικη μορφη περιλαμβανουσα δεσμοπρεσσινη | |
| AR067018A1 (es) | Inhalador | |
| MY142792A (en) | Azolopyridin-2-one derivatives as inhibitors of lipases and phospholipases | |
| CY1115516T1 (el) | Φαρμακευτικη συνθεση που περιεχει ενα συνδυασμο ενος μη στεροειδικου αντιφλεγμονωδους παραγοντα και ενος αντισπασμωδικου παραγοντα | |
| CY1109865T1 (el) | Συνθεσεις βαλσαρτανης | |
| MY146444A (en) | Benzooxazol-2-one derivatives as inhibitors of lipases and phospholipases |